Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

189.27
Delayed Data
As of 4:02pm ET
 +2.12 / +1.13%
Today’s Change
182.80
Today|||52-Week Range
256.80
-9.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line15.2B1.2M-2.6B-723.9M
 
 
 
 
 
Depreciation1.6B1.7B1.8B1.8B
 
 
 
 
 
Total Other Cash Flow-18.2B-415.1M2.5B866.8M
 
 
 
 
 
Funds From Operations-1.6B342.9M959.1M1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-459.8M426.2M235.8M-454.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.1B-83.3M723.3M1.6B
 
 
 
 
 
 
InvestingIncrease In Investments-15.4B-298.0M-6.4B-400.0M
 
 
 
 
 
Capital Expenditures-67.7M-80.9M-33.2M-104.0M
 
 
 
 
 
Fixed Asset Disposal33.3B499.7M700.0K3.6M
 
 
 
 
 
Net Assets From Acquisitions -74.5M-1.1B-2.9B-2.4B
 
 
 
 
 
Other Investing - Sources40.0M7.7B9.7B3.5B
 
 
 
 
 
Net Cash Flow Investing17.8B6.7B14.2M385.8M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings150.0M0.000.003.0B
 
 
 
Long Term Debt Reduction-7.0B-17.7M-1.0B-4.6B
 
 
 
 
 
Net Proceeds Stock Sale30.7M34.1M52.6M72.1M
 
 
 
 
 
Common Preferred Redeemed-2.7B-12.3B-29.5M-5.7M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-69.6M-69.6M-305.8M-306.1M
 
 
 
 
 
Other Sources - Financing-5.3M-6.2M----
 
 
 
Other Uses - Financing13.9M83.4M76.3M428.8M
 
 
 
 
 
Net Cash Flow - Financing-9.6B-12.5B-1.4B-2.2B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.3M-12.8M6.3M5.2M
 
 
 
 
 
 
Net Change In Cash7.1B-5.8B-637.4M-211.2M